
Jason Michael Nolan
Examiner (ID: 1790)
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1623, 1626 |
| Total Applications | 716 |
| Issued Applications | 442 |
| Pending Applications | 91 |
| Abandoned Applications | 197 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5534190
[patent_doc_number] => 20090233978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders'
[patent_app_type] => utility
[patent_app_number] => 12/334432
[patent_app_country] => US
[patent_app_date] => 2008-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62578
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20090233978.pdf
[firstpage_image] =>[orig_patent_app_number] => 12334432
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/334432 | Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders | Dec 11, 2008 | Abandoned |
Array
(
[id] => 6026423
[patent_doc_number] => 20110053997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => ' Salts and Crystal Forms'
[patent_app_type] => utility
[patent_app_number] => 12/746239
[patent_app_country] => US
[patent_app_date] => 2008-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 173
[patent_figures_cnt] => 173
[patent_no_of_words] => 48953
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20110053997.pdf
[firstpage_image] =>[orig_patent_app_number] => 12746239
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/746239 | Salts and Crystal Forms | Dec 4, 2008 | Abandoned |
Array
(
[id] => 8784874
[patent_doc_number] => 08431717
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-30
[patent_title] => 'Process for the preparation of 5-(2-ethyl-dihydro-1H-inden-2-yl)-1H-imidazole and salts thereof'
[patent_app_type] => utility
[patent_app_number] => 12/734777
[patent_app_country] => US
[patent_app_date] => 2008-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2780
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12734777
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/734777 | Process for the preparation of 5-(2-ethyl-dihydro-1H-inden-2-yl)-1H-imidazole and salts thereof | Dec 2, 2008 | Issued |
Array
(
[id] => 123228
[patent_doc_number] => 07705026
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-27
[patent_title] => 'Biaryl heterocyclic compounds and methods of making and using the same'
[patent_app_type] => utility
[patent_app_number] => 12/275941
[patent_app_country] => US
[patent_app_date] => 2008-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57735
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/705/07705026.pdf
[firstpage_image] =>[orig_patent_app_number] => 12275941
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/275941 | Biaryl heterocyclic compounds and methods of making and using the same | Nov 20, 2008 | Issued |
Array
(
[id] => 6267634
[patent_doc_number] => 20100298391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'AMIDE COMPOUNDS AND USE THEREOF FOR PLANT DISEASE CONTROL'
[patent_app_type] => utility
[patent_app_number] => 12/734723
[patent_app_country] => US
[patent_app_date] => 2008-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8808
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20100298391.pdf
[firstpage_image] =>[orig_patent_app_number] => 12734723
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/734723 | AMIDE COMPOUNDS AND USE THEREOF FOR PLANT DISEASE CONTROL | Nov 18, 2008 | Abandoned |
Array
(
[id] => 4529813
[patent_doc_number] => 07923466
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-12
[patent_title] => '3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase I'
[patent_app_type] => utility
[patent_app_number] => 12/269216
[patent_app_country] => US
[patent_app_date] => 2008-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30148
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/923/07923466.pdf
[firstpage_image] =>[orig_patent_app_number] => 12269216
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/269216 | 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase I | Nov 11, 2008 | Issued |
Array
(
[id] => 6499544
[patent_doc_number] => 20100286212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'Treating and Preventing Viral Infections'
[patent_app_type] => utility
[patent_app_number] => 12/682341
[patent_app_country] => US
[patent_app_date] => 2008-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 23799
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 60
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286212.pdf
[firstpage_image] =>[orig_patent_app_number] => 12682341
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/682341 | Treating and preventing viral infections | Oct 30, 2008 | Issued |
Array
(
[id] => 5447101
[patent_doc_number] => 20090048327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'Polymorphs of Pyrrole Substituted 2-Indolinone Protein Kinase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/250068
[patent_app_country] => US
[patent_app_date] => 2008-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6950
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20090048327.pdf
[firstpage_image] =>[orig_patent_app_number] => 12250068
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/250068 | Polymorphs of Pyrrole Substituted 2-Indolinone Protein Kinase Inhibitors | Oct 12, 2008 | Abandoned |
Array
(
[id] => 5474603
[patent_doc_number] => 20090247769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'COLORANT'
[patent_app_type] => utility
[patent_app_number] => 12/244103
[patent_app_country] => US
[patent_app_date] => 2008-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6472
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20090247769.pdf
[firstpage_image] =>[orig_patent_app_number] => 12244103
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/244103 | Colorant | Oct 1, 2008 | Issued |
Array
(
[id] => 5509215
[patent_doc_number] => 20090082422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'DEUTERIUM-ENRICHED LEVETIRACETAM'
[patent_app_type] => utility
[patent_app_number] => 12/233651
[patent_app_country] => US
[patent_app_date] => 2008-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2898
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20090082422.pdf
[firstpage_image] =>[orig_patent_app_number] => 12233651
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/233651 | DEUTERIUM-ENRICHED LEVETIRACETAM | Sep 18, 2008 | Abandoned |
Array
(
[id] => 5509213
[patent_doc_number] => 20090082420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'DEUTERIUM-ENRICHED VILDAGLIPTIN'
[patent_app_type] => utility
[patent_app_number] => 12/233322
[patent_app_country] => US
[patent_app_date] => 2008-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3292
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20090082420.pdf
[firstpage_image] =>[orig_patent_app_number] => 12233322
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/233322 | DEUTERIUM-ENRICHED VILDAGLIPTIN | Sep 17, 2008 | Abandoned |
Array
(
[id] => 5310902
[patent_doc_number] => 20090018183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-15
[patent_title] => 'N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands'
[patent_app_type] => utility
[patent_app_number] => 12/232399
[patent_app_country] => US
[patent_app_date] => 2008-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5900
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20090018183.pdf
[firstpage_image] =>[orig_patent_app_number] => 12232399
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/232399 | N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands | Sep 16, 2008 | Abandoned |
Array
(
[id] => 5429125
[patent_doc_number] => 20090088435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'METHODS AND COMPOUNDS FOR TREATING RETINOL-RELATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/210802
[patent_app_country] => US
[patent_app_date] => 2008-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 41346
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20090088435.pdf
[firstpage_image] =>[orig_patent_app_number] => 12210802
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/210802 | Methods and compounds for treating retinol-related diseases | Sep 14, 2008 | Issued |
Array
(
[id] => 8846481
[patent_doc_number] => 08455663
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-04
[patent_title] => 'Halosubstituted aryloxyalkylimidazolines for use as pesticides'
[patent_app_type] => utility
[patent_app_number] => 12/677825
[patent_app_country] => US
[patent_app_date] => 2008-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14640
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12677825
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677825 | Halosubstituted aryloxyalkylimidazolines for use as pesticides | Sep 8, 2008 | Issued |
Array
(
[id] => 5272345
[patent_doc_number] => 20090076121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'DEUTERIUM-ENRICHED SUMATRIPTAN'
[patent_app_type] => utility
[patent_app_number] => 12/206417
[patent_app_country] => US
[patent_app_date] => 2008-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3592
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076121.pdf
[firstpage_image] =>[orig_patent_app_number] => 12206417
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/206417 | DEUTERIUM-ENRICHED SUMATRIPTAN | Sep 7, 2008 | Abandoned |
Array
(
[id] => 5272348
[patent_doc_number] => 20090076124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'DEUTERIUM-ENRICHED ROPINIROLE'
[patent_app_type] => utility
[patent_app_number] => 12/206307
[patent_app_country] => US
[patent_app_date] => 2008-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4058
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076124.pdf
[firstpage_image] =>[orig_patent_app_number] => 12206307
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/206307 | DEUTERIUM-ENRICHED ROPINIROLE | Sep 7, 2008 | Abandoned |
Array
(
[id] => 5272507
[patent_doc_number] => 20090076283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Method of crystallizing carvedilol phosphate and the product thereof'
[patent_app_type] => utility
[patent_app_number] => 12/231760
[patent_app_country] => US
[patent_app_date] => 2008-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 307
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076283.pdf
[firstpage_image] =>[orig_patent_app_number] => 12231760
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/231760 | Method of crystallizing carvedilol phosphate and the product thereof | Sep 4, 2008 | Abandoned |
Array
(
[id] => 8375383
[patent_doc_number] => 08258176
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-04
[patent_title] => 'Dithiolopyrrolone compounds, the preparation and the use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/676470
[patent_app_country] => US
[patent_app_date] => 2008-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12346
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12676470
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/676470 | Dithiolopyrrolone compounds, the preparation and the use thereof | Aug 28, 2008 | Issued |
Array
(
[id] => 239615
[patent_doc_number] => 07592332
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-22
[patent_title] => 'Cytokine inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/201766
[patent_app_country] => US
[patent_app_date] => 2008-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19489
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/592/07592332.pdf
[firstpage_image] =>[orig_patent_app_number] => 12201766
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/201766 | Cytokine inhibitors | Aug 28, 2008 | Issued |
Array
(
[id] => 5324335
[patent_doc_number] => 20090062325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'DEUTERIUM-ENRICHED TIOTROPIUM'
[patent_app_type] => utility
[patent_app_number] => 12/195907
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3879
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062325.pdf
[firstpage_image] =>[orig_patent_app_number] => 12195907
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/195907 | DEUTERIUM-ENRICHED TIOTROPIUM | Aug 20, 2008 | Abandoned |